Patient Guide: A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 83 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06230224
Status: 🟢 Enrolling Now
Condition: B-Cell Non-Hodgkin Lymphoma (B-NHL)
Phase: PHASE3

Where You Can Participate

This study is available at 83 locations across the country.

Top locations include:
  • • Ciudad Autonoma de Buenos Aires, Buenos Aires
  • • Liverpool, New South Wales
  • • Woolloongabba, Queensland
  • • And 80 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma - Join Clinical Trial NCTNCT06230224

How to Join This Clinical Trial - NCTNCT06230224

Learn how to participate in this PHASE3 trial studying an investigational therapy for B-Cell Non-Hodgkin Lymphoma (B-NHL). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with B-Cell Non-Hodgkin Lymphoma (B-NHL). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
B-Cell Non-Hodgkin Lymphoma (B-NHL)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06230224 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 83 locations. Find a study site near you:

Clinical Research Site

Ciudad Autonoma de Buenos Aires, Buenos Aires 1426 - Argentina

Status: RECRUITING

Clinical Research Site

Liverpool, New South Wales 2170 - Australia

Status: WITHDRAWN

Clinical Research Site

Woolloongabba, Queensland 4102 - Australia

Status: RECRUITING

Clinical Research Site

Hobart, Tasmania 7000 - Australia

Status: RECRUITING

Clinical Research Site

Heidelberg, Victoria 3084 - Australia

Status: RECRUITING

Clinical Research Site

Salvador, Estado de Bahia 40050-410 - Brazil

Status: RECRUITING

Clinical Research Site

Salvador, Estado de Bahia 40285-000 - Brazil

Status: RECRUITING

Clinical Research Site

Salvador, Estado de Bahia 41950-640 - Brazil

Status: RECRUITING

Clinical Research Site

Brasília, Federal District 70200-730 - Brazil

Status: RECRUITING

Clinical Research Site

Cascavel, Paraná 85806-300 - Brazil

Status: RECRUITING

And 73 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for B-Cell Non-Hodgkin Lymphoma (B-NHL):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships